{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:49Z","timestamp":1783181149672,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012175","name":"Zhejiang Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2018ZZ001"],"award-info":[{"award-number":["2018ZZ001"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.abb.2020.108405","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T12:32:17Z","timestamp":1589805137000},"page":"108405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3"],"prefix":"10.1016","volume":"689","author":[{"given":"Meiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2020.108405_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.abb.2020.108405_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/01.CIR.0000055319.94801.FC","article-title":"Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy","volume":"107","author":"Heineke","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.abb.2020.108405_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle","volume":"56","author":"Grossman","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.abb.2020.108405_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/CIRCULATIONAHA.106.613562","article-title":"The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.abb.2020.108405_bib5","doi-asserted-by":"crossref","first-page":"20773","DOI":"10.18632\/oncotarget.4770","article-title":"Exercise for the heart: signaling pathways","volume":"6","author":"Tao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.abb.2020.108405_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvr015","article-title":"Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy","volume":"90","author":"Abel","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.abb.2020.108405_bib7","first-page":"100503","article-title":"Hypertrophic cardiomyopathy","volume":"27","author":"Antunes","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.abb.2020.108405_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ng865","article-title":"Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation","volume":"30","author":"Lai","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.abb.2020.108405_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.abb.2020.108405_bib10","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.abb.2020.108405_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCRESAHA.118.312751","article-title":"miR-146a suppresses SUMO1 expression and induces cardiac dysfunction in maladaptive hypertrophy","volume":"123","author":"Oh","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.abb.2020.108405_bib12","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41467-017-01737-4","article-title":"Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling","volume":"8","author":"Sassi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2020.108405_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCRESAHA.115.306624","article-title":"miR-206 mediates YAP-induced cardiac hypertrophy and survival","volume":"117","author":"Yang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.abb.2020.108405_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.abb.2020.108405_bib15","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/brain\/awr262","article-title":"Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity","volume":"134","author":"Guerau-de-Arellano","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.abb.2020.108405_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1172\/JCI88415","article-title":"Excessive expression of miR-27 impairs Treg-mediated immunological tolerance","volume":"127","author":"Cruz","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.abb.2020.108405_bib17","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2011-07-370635","article-title":"miR-27b controls venous specification and tip cell fate","volume":"119","author":"Biyashev","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.abb.2020.108405_bib18","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.1073\/pnas.1105254108","article-title":"Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters","volume":"108","author":"Zhou","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2020.108405_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvn156","article-title":"Role of microRNAs in vascular diseases, inflammation, and angiogenesis","volume":"79","author":"Urbich","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.abb.2020.108405_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2012.01.020","article-title":"The magic and mystery of microRNA-27 in atherosclerosis","volume":"222","author":"Chen","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.abb.2020.108405_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.abb.2020.108405_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.abb.2020.108405_bib23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.abb.2020.108405_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.abb.2020.108405_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.abb.2020.108405_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.abb.2020.108405_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.abb.2020.108405_bib28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","article-title":"Myocardial galectin-3 expression is associated with remodeling of the pressure-overloaded heart and May delay the hypertrophic response without affecting survival, dysfunction, and cardiac fibrosis","volume":"186","author":"Frunza","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.abb.2020.108405_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbrc.2016.10.052","article-title":"HMGB1 induces human non-small cell lung cancer cell motility by activating integrin alphavbeta3\/FAK through TLR4\/NF-kappaB signaling pathway","volume":"480","author":"Zhu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2020.108405_bib30","first-page":"3834","article-title":"The TLR4\/NF-kappaB signaling pathway mediates the growth of colon cancer","volume":"18","author":"Huang","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.abb.2020.108405_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.intimp.2017.12.019","article-title":"Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4\/NF-kappaB signaling pathway in mice","volume":"55","author":"Ma","year":"2018","journal-title":"Int. Immunopharm."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120304148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120304148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:36:06Z","timestamp":1779986166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986120304148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"alternative-id":["S0003986120304148"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2020.108405","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2020.108405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108405"}}